Returning investor in Hangzhou Highlightll Pharmaceutical's Pre-Series C financing, led by Huajin Capital, Bayland Capital, and Infinity Capital.
Highlightll is a clinical stage biopharmaceutical company focusing on both peripheral and central autoimmune/inflammatory diseases
Highlightll is a clinical stage biopharmaceutical company focusing on both peripheral and central autoimmune/inflammatory diseases. We strive to discover breakthrough medicines which would have a high impact on health care.